ARMODAFINIL

ARMODAFINIL (10919Q)

armodafinil 250 mg tablet, 30
10919Q
Body System:
Manner of administration:Oral
General Schedule
Authority Required

Restriction

Indication: Narcolepsy
Treatment phase: Initial 1 - treatment of narcolepsy without cataplexy

Restriction

Indication: Narcolepsy
Treatment phase: Initial 2 - treatment of narcolepsy with cataplexy

Restriction

Indication: Narcolepsy
Treatment phase: Continuing or change of treatment
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 30 # of repeats: 5 DPMQ: $245.28 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Nuvigil